CAS 1803084-79-8
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
6 produits concernés.
Repaglinide Related Compound C ((S)-2-Ethoxy-4-[2-[[2-phenyl-1-[2-(1-piperidinyl)phenyl]ethyl]amino]-2-oxoethyl] benzoic acid)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C30H34N2O4Couleur et forme :White PowderMasse moléculaire :486.25186Benzoic acid, 2-ethoxy-4-[2-oxo-2-[[(1S)-2-phenyl-1-[2-(1-piperidinyl)phenyl]ethyl]amino]ethyl]-
CAS :Formule :C30H34N2O4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :486.6020(S)-2-Ethoxy-4-(2-oxo-2-((2-phenyl-1-(2-(piperidin-1-yl)phenyl)ethyl)amino)ethyl)benzoic acid
CAS :(S)-2-Ethoxy-4-(2-oxo-2-((2-phenyl-1-(2-(piperidin-1-yl)phenyl)ethyl)amino)ethyl)benzoic acidDegré de pureté :98%Masse moléculaire :486.61g/molRepaglinide C
CAS :Repaglinide C is a medicinal compound that has been shown to be a potent inhibitor of human protein kinases. It has demonstrated anticancer activity in Chinese hamster ovary and human cancer cell lines, inducing apoptosis and inhibiting tumor growth. Repaglinide C is an analog of the kinase inhibitor staurosporine, which is known for its broad-spectrum activity against various kinases. Repaglinide C has been found to have a high potency against several kinases involved in cancer cell signaling pathways, making it a promising candidate for cancer therapy. This compound has also been detected in human urine samples, suggesting potential use as a biomarker for monitoring kinase inhibitor therapy.Formule :C30H34N2O4Degré de pureté :Min. 95%Masse moléculaire :486.6 g/mol
![Benzoic acid, 2-ethoxy-4-[2-oxo-2-[[(1S)-2-phenyl-1-[2-(1-piperidinyl)phenyl]ethyl]amino]ethyl]-](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb%2FDA01FPKT.jpg&w=3840&q=75)
